100840-50-4

Upstream product

• 904-10-9 N-[3-(4-Nitrophenoxy)propyl]phthalimide 
• 100-02-7 4-nitro-phenol 
• 5460-29-7 2-(3-bromopropyl)isoindole-1,3-dione 
• 28341-54-0 4-(4-nitrophenoxy)butanoic acid 
• 42251-84-3 N-(3-chloropropyl)phthalimide 
• 103-90-2 4-acetaminophenol 
• 101243-52-1 N-[3-(4-acetylamino-phenoxy)-propyl]-phthalimide 

Downstream Products

• 111241-28-2 tri-N-methyl-4-(3-phthalimido-propoxy)-anilinium; iodide 
• 31352-38-2 4-(3-amino-propoxy)-aniline 
• 100840-54-8 N-<3-<4-(4-methylbenzenesulfonamido)phenoxy>-propyl>phthalimide 
• 902451-74-5 4-{4-[(3-phthalimidopropyl)oxy]phenylazo}phenol 
• 102081-56-1 N-[3-(4-dimethylamino-phenoxy)-propyl]-phthalimide 
• 902451-81-4 1-{4-[(3-phthalimidopropyl)oxy]phenylazo}-4-[3,4,5-tris(dodecan-1-yloxy)benzyloxy]benzene 
• 902451-87-0 1-{4-[(3-aminopropyl)oxy]phenylazo}-4-[3,4,5-tris(n-dodecan-1-yloxy)-benzyloxy]benzene 
• 902451-77-8 4-dodecyloxy-1-{4-[(3-phthalimidopropyl)oxy]phenylazo}benzene 
• 902451-79-0 4-[(2-ethylhexyl)oxy]-1-{4-[(3-phthalimidopropyl)oxy]phenylazo}benzene 
• 902451-83-6 1-{4-[(3-aminopropyl)oxy]phenylazo}-4-dodecyloxybenzene 
• 902451-85-8 1-{4-[(3-aminopropyl)oxy]phenylazo}-4-[(2-ethylhexyl)oxy]benzene 
• 757236-75-2 p-(diphenylphosphorylacetamino)phenoxypropylphthalimide 

Relevant academic research and scientific papers

Photoresponsive self-assembly and self-organization of hydrogen-bonded supramolecular tapes

Self-assembling building blocks that are readily functionalizable and capable of achieving programmed hierarchical organization have enabled us to create various functional nanomaterials. We have previously demonstrated that N,N′-disubstituted 4,6-diamino

Separation of lanthanides and actinides using magnetic silica particles bearing covalently attached tetra-CMPO-calix[4] arenes

Calix[4]arene tetraethers in the cone conformation bearing four -NH-CO-CH2-P(O)Ph2 (= CMPO) residues on their wide rim and one, two or four ω-amino alkyl residues of various lengths at the narrow rim were synthesized. Reaction with dichlorotriazinyl (DCT) functionalized magnetic particles led to complete coverage of the available surface by covalently linked CMPO-calix[4]arenes in all cases. Magnetically assisted removal of Eu(III) and Am(III) from acidic solutions was distinctly more efficient with these particles in comparison to analogous particles bearing the same amount of analogous single-chain CMPO-functions. The best result, an increase of the extraction efficiency by a factor of 140-160, was obtained for attachment via two propyl spacers. The selectivity Am/Eu was in the range of 1.9-2.8. No decrease of the extraction ability was observed, when the particles were repeatedly used, after simple back extraction with water.

N-?4-(imidazolyl or pyrazolyl)phenyl(oxy, sulfinyl, sulfenyl or sulfonyl)alkyl!carboxamides, sulfonamides or phosphoramides having antiarrhythmic properties

The present invention relates to substituted ω-?phenoxy, phenylthio, phenylsulfinyl, phenylsulfonyl! ?alkyl, alkenyl or alkynyl!amine carboxamides, sulfonamides and phosphonylamides which are useful as antiarrhythmic agents.

N-(Phenoxyalkyl) carboxamides and their use as antiarrhythmic agents

The present invention relates to substituted ω-[phenoxy, phenylthio, phenylsulfinyl, phenylsulfonyl] [alkyl, alkenyl or alkynyl]amine carboxamides, sulfonamides and phosphonylamides which are useful as antiarrhythmic agents.

Phenylcarboxylic acid derivatives

Phenylcarboxylic acid derivatives having the formula: STR1 wherein R1 and R2 are each H, halogen, alkyl, haloalkyl, alkanoyl, cycloalkyl, nitro, amino, --O--D--R5 (D is alkylene, R5 is H, amino, morpholino, carboxyl, phthalimido, phenyl, epoxy), substituted or unsubstituted phenoxy, substituted or unsubstituted phenylalkylamino, carboxylalkenyl, or both form alkylenedioxy; R3 is H, --E--R6 (E is alkylene, R6 is H, carboxyl, cyano, OH, phenylalkoxy, or halogen-substituted phenyl, or phenylcarbamoyl), --CO--G--R7 (G is alkylene, R7 is H, substituted or unsubstituted phenylcarbamoyl), substituted or unsubstituted benzoyl, alkenyl, carbamoyl, phenyl, or halophenyl; R4 is H or alkyl; A is alkylene, alkylene condensed with cycloalkyl ring, or alkenylene; B is alkylene or alkenylene; l is 0 or 1. Said compounds have fatty acid synthesis-inhibitory activity, cholesterol synthesis-inhibitory activity and are useful as antilipidemic agent, prophylactic and treating agent of artherosclerosis, prophylactic and treating agent of obesity, antidiabetics.